Sign In

Login

Password

Forgot Password ? Sign Up

Teneligliptin (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Teneligliptin" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
3doi.org
2nd place
2nd place
2nih.gov
4th place
7th place
1daiichisankyo.com
low place
low place

daiichisankyo.com

doi.org

  • Kishimoto, M (2013). “Teneligliptin: A DPP-4 inhibitor for the treatment of type 2 diabetes”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 6: 187–95. doi:10.2147/DMSO.S35682. PMC 3650886. PMID 23671395.
  • Joanne Bronson; Amelia Black; T. G. Murali Dhar; Bruce A. Ellsworth; J. Robert Merritt (2013). Teneligliptin (Antidiabetic), Chapter: To Market, To Market - 2012. Annual Reports in Medicinal Chemistry. 48. tr. 523–524. doi:10.1016/b978-0-12-417150-3.00028-4. ISBN 9780124171503.
  • Nabeno, Mika; Akahoshi, Fumihiko; Kishida, Hiroyuki; Miyaguchi, Ikuko; Tanaka, Yoshihito; Ishii, Shinichi; Kadowaki, Takashi (2013). “A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site”. Biochemical and Biophysical Research Communications. 434 (2): 191–196. doi:10.1016/j.bbrc.2013.03.010.

nih.gov

ncbi.nlm.nih.gov

  • Kishimoto, M (2013). “Teneligliptin: A DPP-4 inhibitor for the treatment of type 2 diabetes”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 6: 187–95. doi:10.2147/DMSO.S35682. PMC 3650886. PMID 23671395.

pubmed.ncbi.nlm.nih.gov

  • Kishimoto, M (2013). “Teneligliptin: A DPP-4 inhibitor for the treatment of type 2 diabetes”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 6: 187–95. doi:10.2147/DMSO.S35682. PMC 3650886. PMID 23671395.